FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.
The US Food and Drug Administration will not object to the use of certain qualified health claims regarding consuming certain cranberry juice and supplements and a reduced risk of recurrent urinary tract infection (UTI) in healthy women.
UK watchdogs are reminding firms that stating or implying substances in food supplements can prevent, treat or cure disease is prohibited as authorities look to clamp down on recent coronavirus-related claims.
NZMP, the global dairy ingredients brand of Fonterra, has announced a European patent has been granted allowing NZMP customers the ability to position their products as beneficial for cognitive development.
New recommendations that address the safety of biological products containing live microorganisms, may help firms obtain a marketing authorisation that is so far proving elusive, according to a research team
A report believes the reduction of chronic digestive disease risk and improvements to gut microbiome health can be achieved by changing behaviours and attitudes towards food consumption and production.
The UK could be set to emerge as a global leader in the research and development of CBD as a food ingredient after the news that the European Commission has postponed the Novel Food applications of non-synthetic CBD products as it decides whether to class...
Kombucha Brewers International (KBI), the trade association committed to promoting and protecting commercial kombucha brewers around the world, has released the industry’s first Code of Practice, a food safety and quality standard for kombucha producers...